GEriatric Determinants of Curative RAdiotherapy Scheme Choice for Breast Cancer ELderly Patient Treatment Compliance and Tolerance
NCT02994914 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 241
Last updated 2022-02-22
Summary
This study proposes an onco geriatric evaluation (Activities of Daily Living, Instrumental Activities Of Daily Living, Mini Mental State Examination, mini Geriatric Depression Scale, Mini Nutritional Assessment, Cumulative Illness Rating Scale-Geriatric, and " timed get up and go " tests) for elderly breast cancer patients. The score obtained at this evaluation will determine the radiotherapy scheme.
Conditions
Interventions
- OTHER
-
Onco Geriatric Evaluation
Seven tests will be performed by an onco geriatrician : Activities of Daily Living, Instrumental Activities Of Daily Living, Mini Mental State Examination, mini Geriatric Depression Scale, Mini Nutritional Assessment, Cumulative Illness Rating Scale-Geriatric, and " timed get up and go " tests. Those tests lead to a score, and this score will determine the scheme of patients radiotherapy.
Sponsors & Collaborators
-
Centre Antoine Lacassagne
collaborator OTHER -
Institut de Cancérologie de la Loire
collaborator OTHER -
Centre Hospitalier Universitaire de Saint Etienne
lead OTHER
Principal Investigators
-
Nicolas Magné, PhD · Institut de Cancérologie Lucien Neuwirth
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-05
- Primary Completion
- 2020-06-26
- Completion
- 2020-06-26
Countries
- France
Study Locations
More Related Trials
-
EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer
NCT02889874 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
TOxicity After Radiotherapy in breAst CancEr Survivors (ThORACeS) - A Retrospective Cohort Study
NCT02471079 ·Status: COMPLETED
-
Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not
NCT01553903 ·Status: COMPLETED ·Phase: PHASE4
-
Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment
NCT05928325 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer
NCT03731845 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer
NCT04740697 ·Status: RECRUITING ·Phase: NA
-
Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy
NCT00542594 ·Status: TERMINATED
-
Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
NCT03351062 ·Status: RECRUITING ·Phase: PHASE3
-
Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer
NCT04272801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer
NCT01612871 ·Status: COMPLETED ·Phase: PHASE4
-
Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer
NCT00688909 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
NCT00309478 ·Status: COMPLETED ·Phase: PHASE3
-
Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer
NCT02769104 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer
NCT00248170 ·Status: COMPLETED ·Phase: PHASE3
-
Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer
NCT00422903 ·Status: COMPLETED ·Phase: PHASE2
-
Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer
NCT04693338 ·Status: COMPLETED ·Phase: PHASE1
-
Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer
NCT01622361 ·Status: UNKNOWN ·Phase: PHASE3
-
Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
NCT00332852 ·Status: COMPLETED ·Phase: PHASE3
-
Collaborative Research: Multiscale Modeling and Intervention for Improving Long-Term Medication
NCT06865755 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer
NCT00062400 ·Status: COMPLETED ·Phase: NA
-
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
NCT06033092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Breast Cancer Prevention by Letrozole in High Risk Women
NCT00579826 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women
NCT00237133 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
NCT04961996 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3